Kozuh....et al.
UGNE
Good timing. I have been in this one for over two years with a nice gain...it looks like it is now finally ready to get FDA approval for their Nasal calcitonin product (for oseoporisis). They have major deals with Glaxxo-Smithkline, Upsher and Novartis to market the nasal as well as develop an oral delivery product. Once approved they should get milestone payments, addtl partnering deals, amex application etc. From the yahoo board expectation is is 6Mos from late September FDA data submission would indicate Late March/Early April approval.
Due your own due dilligence.
Unigene Laboratories Inc Website Annual Report
110 Little Falls Road Phone: +1 973 882-0860
Fairfield NEW JERSEY 07004
Fax: +1 973 227-6088
Unigene Laboratories, Inc.. The Group's principal activity is to research, produce and deliver peptides for medical use. The Group has developed manufacturing technology for producing peptides cost-effectively. It has also patented oral and nasal delivery technology that has been shown to deliver medically useful amounts of various peptides into the bloodstream. The initial products of the Group will be injectable, nasal and oral formulations of calcitonin for the treatment of osteoporosis and other indications. The Group has also developed novel drug delivery technology that delivers therapeutic levels of the amidated peptide calcitonin into the bloodstream
****My uninformed opinion only...do your own due diligence****
